QLI Qilian International
- 0.7248
- +0.0078+1.09%
Qilian International News
Qilian International Approves Major Share Restructuring
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. The market value of their outstanding shares is at $7.4 million. Galecto (NASDAQ:GLTO) shares in
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersGalera Therapeutics (NASDAQ:GRTX) shares moved upwards by 62.8% to $0.23 during Monday's pre-market session. The market value of their outstanding shares is at $12.3 million. As per the news, t
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 73.2% to $1.1 during Thursday's after-market session. The company's market cap stands at $39.3 million. Sunshine Biopharma (NASDAQ:SBFM) sha
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersAptorum Gr (NASDAQ:APM) shares moved upwards by 47.1% to $6.37 during Thursday's pre-market session. The company's market cap stands at $33.0 million. Nuvectis Pharma (NASDAQ:NVCT) stock moved
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersMolina Healthcare (NYSE:MOH) stock moved upwards by 24.2% to $503.11 during Wednesday's after-market session. The company's market cap stands at $29.3 billion. Evoke Pharma (NASDAQ:EVOK) shares
Qilian Secures Nasdaq Compliance Extension to July
Qilian International Says It Received 180-day Extension From Nasdaq To Meet Minimum Bid Price Rule
Qilian International Says It Received 180-day Extension From Nasdaq To Meet Minimum Bid Price Rule
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersExicure (NASDAQ:XCUR) stock increased by 29.8% to $0.8 during Wednesday's pre-market session. The company's market cap stands at $6.9 million. Telesis Bio (NASDAQ:TBIO) shares moved upwards by
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersFirst Wave BioPharma (NASDAQ:FWBI) shares increased by 40.8% to $5.38 during Tuesday's after-market session. The company's market cap stands at $3.6 million. Bone Biologics (NASDAQ:BBLG) stock
U.S. Shares Lower at Close of Trade; Dow Jones Industrial Average Down 0.05%
12 Health Care Stocks Moving In Friday's After-Market Session
GainersSensei Biotherapeutics (NASDAQ:SNSE) shares moved upwards by 13.0% to $0.78 during Friday's after-market session. The market value of their outstanding shares is at $20.7 million. Qilian Intl H
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersCardio Diagnostics Hldgs (NASDAQ:CDIO) stock rose 53.4% to $0.33 during Tuesday's regular session. Cardio Diagnostics Hldgs's stock is trading at a volume of 130.2 million shares as of 13:31 ES
Qilian International Holding Group First Half 2023 Earnings: EPS: US$0.014 (Vs US$0.002 in 1H 2022)
Qilian International Gets Noncompliance Notice From Nasdaq
Qilian International (QLI) said Monday the Nasdaq notified the company that it is not in compliance with the exchange's $1 minimum bid price requirement for continued listing. The China-based pharmace
Qilian International Holding Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Qilian International Holding Group Ltd (NASDAQ:QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, received notification (the "Notification Letter") from
Investors Can Find Comfort In Qilian International Holding Group's (NASDAQ:QLI) Earnings Quality
The market for Qilian International Holding Group Limited's (NASDAQ:QLI) shares didn't move much after it posted weak earnings recently. We did some digging, and we believe the earnings are stronger
Qilian International (QLI.US) submitted an annual report and received a notice of re-compliance from NASDAQ
The Zhitong Finance App learned that Qilian International (QLI.US) has once again received the NASDAQ compliance notice. On February 24, 2023, Qilian International received a non-compliance notice from NASDAQ regarding the failure to submit the report for the fiscal year ending September 30, 2022 (document 20-F) in a timely manner. On April 19, Qilian International submitted Form 20-F; on April 20, the company received a second letter from NASDAQ stating that, according to the company's Form 20-F submitted on April 19, 2023, NASDAQ had determined that the company complied with the rules. As a result, Nasdaq informed the company that it now considers the case closed
Qilian Received A Letter From Nasdaq Related To Regain Compliance
Qilian International Holding Group Limited (NASDAQ:QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, previously announced that on February 16, 2023, it
Analysis
Price Target
No Data
